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In 2012–13, all states and territories had rates of 
hospital-associated Staphylococcus aureus bacteraemia 
(SAB) below the national benchmark, with rates ranging 
from 0.7 to 1.3 cases per 10,000 patient days.
There were 1,724 cases of hospital-associated SAB  
reported for Australia, which occurred during 
approximately 18.8 million days of patient care. 2012–13
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Summary 
This report presents national information on cases of Staphylococcus aureus bacteraemia (SAB) 
associated with care provided by public hospitals for the period 1 July 2012 to 30 June 2013. 
This report builds on robust national and jurisdictional arrangements to monitor and reduce 
SAB.  
What is SAB? 
• SAB is a serious bloodstream infection that may be associated with hospital care. As 
such, it is known as a type of healthcare-associated infection.  
• Patients who develop bloodstream infections such as SAB are more likely to suffer 
complications that result in a longer stay in hospital and an increased cost of 
hospitalisation. Serious infections can also result in death. 
• In December 2008, Australian health ministers endorsed the reporting of SAB by all 
hospitals to form a national data collection.  
• In addition, in 2008, rates of SAB, including cases caused by methicillin-resistant 
Staphylococcus aureus, were announced as one of the performance indicators to be 
reported by jurisdictions under the National Healthcare Agreement.  
SAB rates in 2012–13 
• In 2012–13, all states and territories had rates of SAB below the national benchmark of 
2.0 cases per 10,000 patient days. The national rate was 0.9 cases per 10,000 patient days. 
• The rates ranged from 0.7 per 10,000 patient days in the Northern Territory to 1.3 per 
10,000 in the Australian Capital Territory. 
• There were 1,724 cases of SAB reported in Australian public hospitals, of which 77% 
were methicillin sensitive, and therefore treatable with commonly used antibiotics.  
• The reported SAB cases occurred during 18.8 million days of patient care under SAB 
surveillance during 2012–13. 
• Between 2010–11 and 2012–13, the national rates of SAB decreased from 1.1 cases per 
10,000 patient days under surveillance to 0.9 cases per 10,000. Rates decreased in New 
South Wales and the Northern Territory, rose in the Australian Capital Territory, and 
fluctuated or remained about the same in the other states.  
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1 Introduction 
This report presents the third year of nationally consistent information on cases of 
Staphylococcus aureus bacteraemia (SAB) associated with public hospitals in Australia. It is 
one of a series of reports the Australian Institute of Health and Welfare (AIHW) publishes on 
hospitals each year. As for previous years, this series has included reports on elective 
surgery waiting times (AIHW 2013a) and emergency department care (AIHW 2013b) for 
2012–13, released in October 2013. A comprehensive report and a summary report on 
Australian hospitals for 2012–13 will be published in April 2014. 
The SAB data in this report match those provided by the AIHW to the Council of Australian 
Governments (COAG) Reform Council report on the National Healthcare Agreement 
(NHA), and the Steering Committee for the Review of Government Service Provision Report 
on government services, both due for publication in the first half of 2014.  
The data also align with data provided by the AIHW to the National Health Performance 
Authority for its reporting on the performance of individual public hospitals, through the 
MyHospitals website.  
Background 
Healthcare-associated infections  
Healthcare-associated infections (HAIs) are acquired by patients during interactions with the 
healthcare system and are caused by microorganisms such as bacteria and viruses (NHMRC 
2010). They include infections acquired during hospitalisation and during care at other 
healthcare facilities. HAIs can be bloodstream infections (bacteraemia) or localised infections, 
such as those associated with surgical sites.  
It is estimated that there are about 200,000 HAIs each year in Australia (Cruickshank & 
Ferguson 2008), making them the most common complication affecting patients in hospital.  
HAIs cause patients pain and suffering, prolonging hospital stays and increasing costs to the 
healthcare system (NHMRC 2010). Some patients die as a result of HAIs, and many of these 
deaths are preventable.  
Staphylococcus aureus and SAB 
Staphylococcus aureus is an important cause of healthcare-associated bacteraemia, causing 
significant illness and death. When associated with healthcare procedures, these infections 
are considered to be potentially preventable.  
When Staphylococcus aureus causes bacteraemia, this is referred to as Staphylococcus aureus 
bacteraemia, or SAB.  
The bacteria causing SAB are frequently found on the skin or in the nose of many individuals 
and are commonly spread from person to person in the community. In this form, they are 
usually harmless and most people are unaware that they are carrying them. 
In hospitals, the transmission is most commonly via the hands of healthcare workers. 
Bacteria from the patient’s skin or from the hand of a healthcare worker can gain direct entry 
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into the patient’s bloodstream if they have open wounds or when intravascular devices, such 
central or peripheral venous catheters, are inserted. 
Patients who have a greater risk of infection than the general public are those who have: 
• open wounds  
• invasive devices such as catheters  
• weakened immune systems (cancer or transplant recipients, very young or older 
patients)  
• chronic disease such as diabetes or severe underlying illness  
• prolonged or recurrent exposure to antibiotics.  
Antibiotic resistance 
Antibiotic resistance can be defined as bacteria’s ability to survive and even replicate during 
a course of treatment with a specific antibiotic.  
Some Staphylococcus aureus bacteria are resistant to methicillin and other antibiotics used to 
treat bloodstream infections. In that case, the infections are referred to as being caused by 
methicillin-resistant Staphylococcus aureus (MRSA).  
In Australia, some Staphylococcus aureus strains in hospital are methicillin resistant, and 
resistant to several other antimicrobial drugs (Nimmo et al. 2003). These emerging resistant 
strains are of particular concern as they are particularly virulent (Cosgrove et al. 2003). 
If the Staphylococcus aureus bacteria are able to be treated with common antibiotics, then these 
infections are referred to as being caused by methicillin-sensitive Staphylococcus aureus 
(MSSA).  
National initiatives to monitor and reduce SAB 
Consistent with the public health importance of HAIs, a range of national and local 
initiatives have been established recently throughout Australia to reduce the occurrence of 
SAB, with leadership provided by the Australian Commission on Safety and Quality in 
Health Care (ACSQHC) (see Box 1). 
These initiatives have been accompanied by the establishment of surveillance arrangements 
in public hospitals to monitor HAIs, and the development of an agreed national definition 
for cases of SAB. These developments mean that nationally consistent data on public 
hospital–associated SAB cases are now available.  
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Box 1: Australian Commission on Safety and Quality in Health Care (ACSQHC) 
initiatives 
Reducing healthcare-associated infections (HAIs) is a major program area for the ACSQHC 
(ACSQHC 2013). The ACSQHC’s HAI program includes a number of national initiatives: 
• The National Antimicrobial Stewardship Initiative aims to improve the safe and 
appropriate use of antimicrobials, reduce patient harm and decrease the incidence of 
antimicrobial resistance in Australian hospitals. 
• The National Surveillance Initiative explores options for a national surveillance system 
to monitor HAIs and provide timely feedback to jurisdictions and clinicians. 
• The National Hand Hygiene Initiative monitors and promotes improvements in hand 
hygiene compliance rates, to reduce HAI and to measure hospital performance in hand 
hygiene. This initiative is managed by Hand Hygiene Australia. 
• The Building Clinician Capacity Initiative aims to address knowledge-based gaps by 
providing educational packages and toolkits for clinical staff working in infection 
control and prevention roles.  
• The National Safety and Quality Health Service (NSQHS) Standard 3 aims to minimise 
the risk to patients in acquiring preventable infections and to enable the effective 
management of infections when they occur by using evidence-based strategies. 
• The National Infection Control Guidelines, in development with the National Health 
and Medical Research Council (NHMRC), to establish a nationally accepted approach 
to infection prevention and control. 
The SAB performance indicator  
In 2008, Australian health ministers endorsed the reporting of data on public hospital–
associated SAB cases by states and territories as part of performance reporting under the 
NHA. These data are reported each year by the COAG Reform Council (CRC). 
The NHA sets out objectives for the Australian, state and territory governments for health 
care services and includes the outcome area—Australians receive appropriate high quality and 
affordable hospital and hospital-related care. The NHA includes public hospital–associated SAB 
as a performance benchmark for safety and quality: 
The rate of Staphylococcus aureus (including MRSA) bacteraemia is no more than 2.0 per 
10,000 occupied bed days for acute care public hospitals by 2011–12 in each state and 
territory.  
A review of the NHA was commissioned in 2011 to evaluate performance reporting issues, 
including revision of the National Health Performance Framework and reducing the number 
of performance indicators. The review recommended that the SAB performance indicator be 
retained (COAG 2012). 
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In summary, the SAB performance indicator includes data on: 
• counts of cases of SAB, with data presented separately for 
– MRSA 
– MSSA 
• the rate of cases of SAB per 10,000 patient days for public hospitals included in SAB 
surveillance arrangements.  
Data are restricted to cases associated with care provided in public hospitals. Cases 
associated with private hospitals and with non-hospital care are excluded. 
The current specification for the performance indicator is provided in Appendix A. 
Data source 
State and territory government health authorities source data on public hospital–associated 
SAB cases from HAI surveillance arrangements in their public hospitals. States and 
territories also provide data on patient days for the rate calculations. The patient day data are 
sourced from data on admitted patient care in public hospitals.  
Data were provided to the AIHW for national collation. A data quality statement for the 
2012–13 collection is included in Appendix B.  
State and territory reporting  
The following states and territories publish data relating to healthcare-associated SAB on 
their websites: 
• New South Wales: Healthcare Associated Infection 
<http://www.health.nsw.gov.au/professionals/hai>. 
• Victoria: Victorian Infection Control Nosocomial Infection Surveillance System 
(VICNISS) hospital-acquired infection surveillance annual report 2009–10 
<http://www.vicniss.org.au/AnnualReport.aspx>. 
• Queensland: Hospital performance (includes hospital-acquired infections) 
<http://www.health.qld.gov.au/hospitalperformance/>. 
• Western Australia: Reports Healthcare Associated Infection Unit  
<http://www.public.health.wa.gov.au/3/455/3/reports__healthcare_associated_infecti
on_unit.pm>. 
• Tasmania: HAI surveillance reports 
<http://www.dhhs.tas.gov.au/peh/tasmanian_infection_prevention_and_control_unit
/publications_and_guidelines>. 
• South Australia: South Australian Infection Control Service  
<http://www.health.sa.gov.au/infectioncontrol/Default.aspx?tabid=147>. 
• Australian Capital Territory: ACT Public Health Services Quarterly Performance Report 
(includes healthcare-associated infection rates) 
<http://health.act.gov.au/publications/reports/act-public-health-services-quarterly-
performance-report/act-public-health-services-quarterly-performance-report>. 
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2 Staphylococcus aureus bacteraemia 
cases  
SAB cases in 2012–13 
There were 1,724 cases of SAB reported for Australian public hospitals in 2012–13. In all 
states and territories, MSSA cases (77%) were more common than MRSA cases. The MSSA 
cases would have been treatable with commonly used antibiotics (Table 2.1). 
The reported SAB cases occurred during 18.8 million days of patient care under SAB 
surveillance during 2012–13. The number of days of patient care under surveillance 
represented 97% of all public hospital patient days. 
At the national level and for each state and territory, the rate of SAB (including MRSA) was 
lower than the national benchmark of 2.0 per 10,000 days of patient care. The rates of SAB 
per 10,000 days of patient care under SAB surveillance ranged from 0.7 in the Northern 
Territory to 1.3 in the Australian Capital Territory. The national rate was 0.9 cases per  
10,000 days of patient care. 
How have SAB rates changed over time? 
Due to the changes in the performance indicator specification, the data presented in this 
publication cannot be directly compared with the rates published in Australian hospital 
statistics 2010–11: Staphylococcus aureus bacteraemia in Australian public hospitals (AIHW 
2011). There were also a number of changes to the numbers of cases previously reported for 
2011–12 as a result of some states and territories undertaking audits of SAB data. Revised 
data for 2011–12 are in Table 2.2. 
Between 2010–11 and 2012–13, the number of SAB cases reported for Australian public 
hospitals decreased from 1,875 to 1,724 cases, a decrease of 8.1% overall, and despite an 
increase in the coverage of days of patient care under SAB surveillance from 90% to 97% 
(tables 2.1 to 2.3). Over this period, MSSA cases consistently accounted for about  
three-quarters of SAB cases. 
Between 2010–11 and 2012–13, the rates of SAB per 10,000 days of patient care under SAB 
surveillance decreased from 1.1 cases to 0.9 cases. Over this period, the rates of SAB per 
10,000 days of patient care decreased in New South Wales and the Northern Territory, rose 
in the Australian Capital Territory, and fluctuated or remained about the same in the other 
states (Figure 2.1). 
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(a) The SAB patient episodes were associated with both admitted patient care and with non-admitted patient care (including emergency 
departments and outpatient clinics). The comparability of the SAB rates among jurisdictions and over time is limited because of coverage 
differences and because the count of patient days reflects the amount of admitted patient activity, but does not necessarily reflect the 
amount of non-admitted patient activity.  
(b) For Queensland, the data for 2010–11 do not include patient days for patients aged 14 and under. 
(c) For 2010–11 and 2011–12, the Western Australian data exclude unqualified days for newborns, specialised psychiatric care units and 
psychiatric hospitals. 
Source: Tables 2.1 to 2.3. 
Figure 2.1: Staphylococcus aureus (including MRSA) bacteraemia rates in public hospitals, states 
and territories, 2010–11 to 2012–13(a) 
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Table 2.1: Cases of Staphylococcus aureus (including MRSA) bacteraemia in public hospitals, MRSA and MSSA, states and territories, 2012–13(a) 
  NSW  Vic Qld WA SA Tas ACT NT Total 
 
Rate per 10,000 days of patient care 
Methicillin-resistant Staphylococcus aureus 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.2 
Methicillin-sensitive Staphylococcus aureus 0.7 0.7 0.8 0.6 0.6 0.9 1.1 0.5 0.7 
Total(b) 1.0 0.9 1.0 0.8 0.8 1.0 1.3 0.7 0.9 
 
Number of cases 
Methicillin-resistant Staphylococcus aureus 206 81 47 22 23 2 7 7 395 
Methicillin-sensitive Staphylococcus aureus 447 344 260 106 91 29 37 15 1,329 
Total  653 425 307 128 114 31 44 22 1,724 
           
Patient days under SAB surveillance (‘000)(c) 6,829 4,717 3,171 1,659 1,502 318 331 312 18,840 
Coverage (per cent)(c)(d) 98 99 96 93 93 86 98 100 97 
(a) The SAB patient episodes were associated with both admitted patient care and with non-admitted patient care (including emergency departments and outpatient clinics). The comparability of the SAB rates among 
jurisdictions and over time is limited because of coverage differences and because the count of patient days reflects the amount of admitted patient activity, but does not necessarily reflect the amount of non-admitted 
patient activity. 
(b) Total may not equal sum of components due to rounding. 
(c) Coverage and patient day estimates may be preliminary.  
(d) Coverage is the number of patient days for hospitals included in the SAB surveillance arrangements as a proportion of total patient days for all public hospitals. 
Source: AIHW National Staphylococcus aureus Bacteraemia Data Collection.   
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Table 2.2: Cases of Staphylococcus aureus (including MRSA) bacteraemia in public hospitals, MRSA and MSSA, states and territories, 2011–12(a)(b) 
  NSW  Vic Qld WA(c) SA Tas ACT NT Total 
 
Rate per 10,000 days of patient care 
Methicillin-resistant Staphylococcus aureus 0.3 0.2 0.2 0.2 0.3 0.1 0.2 0.5 0.2 
Methicillin-sensitive Staphylococcus aureus 0.7 0.8 0.7 0.6 0.6 0.7 0.9 0.8 0.7 
Total(d) 1.0 0.9 0.9 0.7 0.9 0.8 1.1 1.3 0.9 
 
Number of cases 
Methicillin-resistant Staphylococcus aureus 201 82 51 23 42 4 6 15 424 
Methicillin-sensitive Staphylococcus aureus 473 379 220 81 85 23 31 24 1,316 
Total  674 461 271 104 127 27 37 39 1,740 
          
Patient days under SAB surveillance (‘000)(e) 6,735 4,855 3,178 1,392 1,363 318 328 304 18,474 
Coverage (per cent)(e)(f) 97 99 98 83 80 90 98 100 95 
(a) The SAB patient episodes were associated with both admitted patient care and with non-admitted patient care (including emergency departments and outpatient clinics). The comparability of the SAB rates among 
jurisdictions and over time is limited because of coverage differences and because the count of patient days reflects the amount of admitted patient activity, but does not necessarily reflect the amount of non-admitted 
patient activity. 
(b) Note that these data have been updated since the publication of Australian hospital statistics 2011–12: Staphylococcus aureus bacteraemia in Australian public hospitals (AIHW 2013c). 
(c) For Western Australia, data exclude unqualified days for newborns, specialised psychiatric care units and psychiatric hospitals. 
(d)  Total may not equal sum of components due to rounding. 
(e) Coverage and patient day estimates may be preliminary.  
(f) Coverage is the number of patient days for hospitals included in the SAB surveillance arrangements as a proportion of total patient days for all public hospitals.  
Source: AIHW National Staphylococcus aureus Bacteraemia Data Collection. 
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Table 2.3: Cases of Staphylococcus aureus (including MRSA) bacteraemia in public hospitals, MRSA and MSSA, states and territories, 2010–11(a)(b) 
  NSW  Vic Qld(c) WA(d) SA Tas ACT NT  Total  
 
Rate per 10,000 days of patient care 
Methicillin-resistant Staphylococcus aureus 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.3 
Methicillin-sensitive Staphylococcus aureus 0.9 0.7 0.9 0.8 0.7 1.1 0.7 0.9 0.8 
Total(e) 1.3 0.9 1.2 1.0 0.9 1.2 0.9 1.5 1.1 
 
Number of cases 
Methicillin-resistant Staphylococcus aureus 233 118 72 23 31 6 6 16 505 
Methicillin-sensitive Staphylococcus aureus 536 322 218 117 91 36 23 27 1,370 
Total  769 440 290 140 122 42 29 43 1,875 
 
         
Patient days under SAB surveillance (’000) 5,961 4,791 2,453 1,377 1,331 342 310 296 16,862 
Coverage (per cent)(f)  94 99 77 84 81 91 98 100 90 
(a) The SAB cases were associated with both admitted patient care and with non-admitted patient care (including emergency departments and outpatient clinics). The comparability of the SAB rates among jurisdictions 
is limited because of coverage differences and because the count of patient days reflects the amount of admitted patient activity, but does not necessarily reflect the amount of non-admitted patient activity. 
(b) Note that these data have been updated since the publication of Australian hospital statistics 2010–11: Staphylococcus aureus bacteraemia in Australian public hospitals (AIHW 2011). 
(c) For Queensland, data only includes patients aged 14 and over. 
(d) For Western Australia, data exclude unqualified days for newborns, specialised psychiatric care units and psychiatric hospitals 
(e)  Total may not equal sum of components due to rounding. 
(f) Coverage is the number of patient days for hospitals included in the SAB surveillance arrangements as a proportion of total patient days for all public hospitals.  
Source: AIHW National Staphylococcus aureus Bacteraemia Data Collection. 
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Limitations of the data 
While the data are based on the nationally agreed definition of a SAB case, there are 
limitations that affect the comparability of the information.  
Variation in definitions 
The indicator uses an agreed definition of a case of SAB which is used by all states and 
territories. However, there may be imprecise exclusion of cases originating in private 
hospitals and in non-hospital settings due to the inherent difficulties in determining the 
origins of SAB cases.  
States and territories, through their HAI surveillance arrangements, collected the data on 
SAB cases. The arrangements for the collection of data by hospitals and the reporting to state 
and territory health authorities may vary among the jurisdictions.  
Although the previous indicator name stipulated ‘acute care’ public hospitals, all public 
hospitals are included. The provision of ‘acute’ services varies among jurisdictions, so it is 
not possible to exclude ‘non-acute’ hospitals from the indicator in a way that would be 
uniform among all states and territories. Therefore, all hospitals have been included in the 
scope of the indicator so that the same approach is taken for each state and territory.  
Variation in coverage 
The coverage is the number of days of patient care for hospitals in the SAB surveillance 
arrangements as a proportion of total patient days for all public hospitals.  
For most states and territories, there is less than 100% coverage of public hospitals (tables 2.1 
to 2.3) and this may affect the reported rates. It is possible that there will be a lower risk of 
SAB in hospitals not included in the SAB surveillance arrangements, especially where they 
undertake fewer invasive procedures than hospitals which are included. Rates should be 
interpreted in conjunction with information about SAB surveillance coverage.  
To enable better comparison, only patient days for those hospitals/patients that were 
covered by the SAB surveillance arrangements are included (in the denominator). For 
example, if a hospital was not included in the SAB surveillance arrangements for part of the 
year, then the patient days for that part of the year were not included. If part of the hospital 
was not included in the SAB surveillance arrangements (for example, children’s wards, 
psychiatric wards), then patient days for that part of the hospital were not included. Patient 
days for ‘non-acute’ hospitals (such as rehabilitation and psychiatric hospitals) are included 
if the hospital was included in the SAB surveillance arrangements, but not otherwise. 
Data for Queensland for 2010–11 included patient days only for patients aged 14 and older. 
For 2010–11 and 2011–12, the Western Australian data exclude unqualified days for 
newborns, specialised psychiatric care units and psychiatric hospitals. 
Limitations of the denominator 
The SAB cases were associated with both admitted patient care and non-admitted patient 
care (including emergency departments and outpatient clinics). No denominator is available 
to describe the total admitted and non-admitted patient activity of public hospitals. 
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However, the number of patient days for admitted patient activity is used as the 
denominator to take into account the large differences between the sizes of the public 
hospital sectors among the jurisdictions. The comparability of the SAB rates among 
jurisdictions and over time may be limited because the count of patient days reflects the 
amount of admitted patient activity, but does not necessarily reflect the amount of non-
admitted patient activity.  
The amount of hospital activity that patient days reflect varies among jurisdictions and over 
time because of variation in admission practices and casemix differences. 
Patient days are used as the denominator, rather than occupied bed days, because occupied 
bed day data were not available for all states and territories. Patient days are the total 
number of days of stay for all patients who are separated from hospital during a specified 
period—that, is there may have been days of stay that occurred in a previous period(s) but 
are counted in the period in which the patient separated from hospital. Occupied bed days 
are the number of days of stay for all patients that occurred during a specified period. There 
may be some difference between patient days and occupied bed days. However, at the state 
and territory level, for annual figures, there is unlikely to be a marked difference between 
counts of patient days and occupied bed days. 
The patient day data used for the denominator may be preliminary for some hospitals or 
jurisdictions for 2012–13. 
Casemix differences 
The data presented have not been adjusted for any differences in casemix among the states 
and territories. Casemix is a term that refers to the range and types of patients (the mix of 
cases) treated by a hospital or other health service. For SAB, relevant aspects of casemix 
could include patient comorbidities and procedures. 
Comparability of rates 
The comparability of the SAB rates among jurisdictions may be limited because of coverage 
differences and because the count of patient days reflects the amount of admitted patient 
activity, but does not necessarily reflect the amount of non-admitted patient activity. 
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Appendix A: National Healthcare 
Agreement: PI 22–Healthcare associated 
infections, 2014 
Identifying and definitional attributes 
Metadata item type: Indicator 
Indicator type: Progress measure 
Short name: PI 22—Healthcare-associated infections, 2014 
METeOR identifier: 517636 
Registration status: Health, Standard 25/11/2013 
Description: Staphylococcus aureus bacteraemia (SAB) associated with acute 
care public hospitals (excluding cases associated with private 
hospitals and non-hospital care) 
Indicator set: National Healthcare Agreement (2014) Health, Standard 
Outcome area: Hospital and Related Care, Health, Standard 07/07/2010 
Quality statement: National Healthcare Agreement: PI 22—Healthcare-associated 
infections, 2014 QS Health, Standard 
Collection and usage attributes 
Computation description: Acute care public hospitals are defined as all public hospitals 
including those hospitals defined as public psychiatric 
hospitals in the Public Hospital Establishments National 
Minimum Data Set (NMDS). All types of public hospitals are 
included, both those focusing on acute care, and those focusing 
on non-acute or subacute care, including psychiatric, 
rehabilitation and palliative care.  
Unqualified newborns are included in the indicator. Hospital 
boarders and posthumous organ procurement are excluded 
from the indicator.  
A patient episode of SAB is defined as a positive blood culture 
for Staphylococcus aureus. For surveillance purposes, only the 
first isolate per patient is counted, unless at least 14 days has 
passed without a positive blood culture, after which an 
additional episode is recorded. 
A Staphylococcus aureus bacteraemia will be considered to be 
healthcare-associated if: the first positive blood culture is 
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collected more than 48 hours after hospital admission or less 
than 48 hours after discharge, OR, if the first positive blood 
culture is collected 48 hours or less after admission and one or 
more of the following key clinical criteria was met for the 
patient episode of SAB: 
1. SAB is a complication of the presence of an indwelling 
medical device (e.g. intravascular line, haemodialysis 
vascular access, cerebrospinal fluid (CSF) shunt, urinary 
catheter)  
2. SAB occurs within 30 days of a surgical procedure where the 
SAB is related to the surgical site  
3. An invasive instrumentation or incision related to the SAB 
was performed within 48 hours  
4. SAB is associated with neutropenia (<1 x 109) contributed to 
by cytotoxic therapy. 
Exclusions:  
Cases where a known previous positive test has been obtained 
within the last 14 days are excluded. For example: If a patient 
has SAB in which 4 sets of blood cultures are positive over the 
initial 3 days of the patient’s admission only one episode of 
SAB is recorded. If the same patient had a further set of positive 
blood cultures on day 6 of the same admission, these would not 
be counted again, but would be considered part of the initial 
patient episode. 
Note: If the same patient had a further positive blood culture 20 
days after admission (i.e. greater than 14 days after their last 
positive on day 5), then this would be considered a second 
patient episode of SAB. 
Denominator: includes unqualified newborns, excludes 
posthumous organ procurement and hospital boarders.  
See the definition of patient days in the Glossary. Also included 
in the denominator are patient days for unqualified newborns, 
which are not covered in the definition. Patient days for 
unqualified newborns must be reported in addition to patient 
days as defined in the definition.  
Analysis by state and territory is based on location of the 
hospital. 
Presented as: 
• a number, and  
• per 10,000 patient days. 
Coverage: Denominator ÷ Number of patient days for all public 
hospitals in the state or territory. 
Any variation from the specifications by jurisdictions will be 
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footnoted and described in the data quality statement. 
Computation: 10,000 x (Numerator ÷ Denominator).  
Numerator: Number of SAB patient episodes (as defined above) associated 
with acute care public hospitals. 
Denominator: Number of patient days for public acute care hospitals under 
surveillance (i.e. only for hospitals included in the surveillance 
arrangements).  
Include unqualified newborns, exclude posthumous organ 
procurement and hospital boarders. 
Disaggregation: 2012–13—State and territory, by: 
• Methicillin-resistant Staphylococcus aureus 
(MRSA)/Methicillin-sensitive Staphylococcus aureus 
(MSSA).  
Some disaggregation may result in numbers too small for 
publication. 
Comments: Most recent data available for 2014 Council of Australian 
Governments (COAG) Reform Council (CRC) report: 2012–13. 
The number of SAB patient episodes associated with acute 
public hospitals under surveillance includes SAB patient 
episodes associated with all public hospitals, and the number of 
patient days for public acute care hospitals under surveillance 
includes the number of patient days for all public hospitals 
under surveillance.  
For most states and territories, there is less than 100 per cent 
coverage of hospitals. This may impact on the reported rate. For 
those jurisdictions with incomplete coverage of acute care 
public hospitals (in the numerator), only patient days for those 
hospitals that contribute data are included (in the 
denominator). Specifically, if a hospital was not included in the 
SAB surveillance arrangements for part of the year, then the 
patient days for that part of the year are excluded. If part of the 
hospital was not included in the SAB surveillance 
arrangements (e.g. children’s wards, psychiatric wards), then 
patient days for that part of the hospital are excluded. Patient 
days for ‘non-acute’ hospitals (such as rehabilitation and 
psychiatric hospitals) are included if the hospital was included 
in the SAB surveillance arrangements, but not otherwise. 
However, all these patient days are included in the coverage 
rate denominator measure of total number of patient days for 
all public hospitals in a state or territory.  
Some states operate a ‘signal surveillance’ arrangement for 
smaller hospitals whereby the hospital notifies the appropriate 
authority if a SAB case is identified, but the hospital is not 
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considered to have formal SAB surveillance as per larger 
hospitals. Where this arrangement is in place, these hospitals 
should be included as part of the indicator. That is, SAB patient 
episodes and patient days should be included as ‘under 
surveillance’.  
Only episodes associated with acute public hospital care in 
each jurisdiction should be counted. If a case is associated with 
care provided in another jurisdiction (cross-border flows), then 
it is reported (where known) by the jurisdiction where the care 
associated with the SAB occurred. 
There may be patient episodes of SAB identified by a hospital 
which did not originate in the identifying hospital (as 
determined by the definition of a patient episode of SAB), but 
in another public hospital. If the originating hospital is under 
SAB surveillance, then the patient episode of SAB should be 
attributed to the originating hospital and should be included as 
part of the indicator. If the originating hospital is not under 
SAB surveillance, then the patient episode is unable to be 
included in the indicator.  
Patient episodes associated with care provided by private 
hospitals and non-hospital health care are excluded. 
Patient days for unqualified newborns are included. Patient 
days for hospital boarders and posthumous organ procurement 
are excluded. 
Almost all patient episodes of SAB will be diagnosed when the 
patient is an admitted patient. However, the intention is that 
cases are reported whether they were associated with admitted 
patient care or non-admitted patient care in public acute care 
hospitals.  
Where there is significant variation, for example non-coverage 
of cases diagnosed less than 48 hours after admission, in the 
data collection arrangements it will affect the calculation of 
values across states and territories. 
Variation in admission practices across jurisdictions will 
influence the denominator for this indicator, impacting on 
comparability of rates. 
Jurisdictional manuals should be referred to for full details of 
definitions used in infection-control surveillance. 
Note that patient episodes of SAB are just one type of 
healthcare associated infection. Hence, this performance 
indicator is not a complete measure of healthcare associated 
infections for the outcome area of Hospital and hospital related 
care. 
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Representational attributes 
Representation class: Rate 
Data type: Real 
Unit of measure: Episode 
Format: NN[N] 
Data source attributes 
Data sources: Data source 
State/territory infection surveillance data 
Frequency 
Annual 
Data custodian 
State/territory health authorities 
 
Data source 
State/territory admitted patient data 
Frequency 
Annual 
Data custodian 
State/territory health authorities 
 
Accountability attributes 
Reporting requirements: National Healthcare Agreement 
Organisation responsible for 
providing data: 
Australian Institute of Health and Welfare 
Benchmark: National Healthcare Agreement: PB g—Better health: the rate of 
Staphylococcus aureus (including MRSA) bacteraemia is no more 
than 2.0 per 10,000 occupied bed days for acute care public 
hospitals by 2011–12 in each state and territory, 2014 
Further data development / 
collection required: 
Specification: substantial work required; the measure requires 
significant work to be undertaken. 
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Appendix B: Data quality statement for the 
National Staphylococcus aureus 
Bacteraemia Data Collection  
This data quality statement provides information relevant to interpretation of statistics 
derived from the National Staphylococcus aureus Bacteraemia Data Collection (NSABDC). 
Summary of key issues 
• The NSABDC is a data set that includes counts of cases of Staphylococcus aureus 
bacteraemia (SAB) for each public hospital covered by SAB surveillance arrangements, 
and for private hospitals that choose to provide data. 
• Cases of SAB have been reported by all states and territories using the nationally agreed 
case definition. 
• There may be imprecise exclusion of some SAB cases due to the inherent difficulties in 
determining the origins of SAB episodes, such as those originating in non-hospital health 
care settings.  
• For some states and territories, there is less than 100% coverage of public hospitals.  
• The accuracy and comparability of the rates of SAB among jurisdictions and over time is 
also limited because the count of patient days (denominator) reflects the amount of 
admitted patient activity, but does not reflect the amount of non-admitted patient 
activity.  
• The data for 2012–13 are comparable with those from 2011–12 except for Western 
Australia. 
• The data for 2011–12 are comparable with those from 2010–11 except for Queensland.  
• Western Australian data for 2010–11 and 2011–12 are not comparable with data from 
other jurisdictions. 
• Due to changes in the performance indicator specification, the data for 2010–11, 2011–12 
and 2012–13 as published in Australian hospital statistics 2012–13: Staphylococcus aureus 
bacteraemia in Australian public hospitals are not comparable with the data published in the 
Australian hospital statistics 2010–11: Staphylococcus aureus bacteraemia in Australian 
public hospitals (AIHW 2011). In addition, some data for 2011–12 have been updated since 
previously published. 
• The patient days and coverage data may be preliminary for some hospitals or 
jurisdictions. 
Description 
The NSABDC includes counts of cases of SAB for each public hospital covered by SAB 
surveillance arrangements, and for private hospitals that choose to provide data. 
The data for public hospitals are collected under hospital infection control arrangements by 
state and territory health authorities. Data on methicillin-resistant Staphylococcus aureus 
(MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) cases for public hospitals are 
reported separately at a state or territory level.  
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The data include the counts of patient days under surveillance.  
Data for SAB cases in private hospitals are provided directly to the Australian Institute of 
Health and Welfare (AIHW) by individual hospitals or hospital groups. 
A case (patient episode) of SAB is defined as a positive blood culture for Staphylococcus 
aureus. For surveillance purposes, only the first isolate per patient is counted, unless at least 
14 days has passed without a positive blood culture, after which an additional episode is 
recorded.  
A case of SAB will be considered to be healthcare-associated if: the first positive blood 
culture is collected more than 48 hours after hospital admission or less than 48 hours after 
discharge, or, if the first positive blood culture is collected 48 hours or less after admission 
and one or more of the following key clinical criteria was met for the patient episode of SAB: 
1. SAB is a complication of the presence of an indwelling medical device (for example, 
intravascular line, haemodialysis vascular access, cerebrospinal fluid shunt, urinary 
catheter) 
2. SAB occurs within 30 days of a surgical procedure where the SAB is related to the surgical 
site 
3. an invasive instrumentation or incision related to the SAB was performed within 48 hours 
4. SAB is associated with neutropenia (<1 x 109) contributed to by cytotoxic therapy. 
This definition of a case of SAB was used by all states and territories for reporting for  
2010–11 and subsequent years.  
Institutional environment 
The AIHW is a major national agency set up by the Australian Government under the 
Australian Institute of Health and Welfare Act 1987 to provide reliable, regular and relevant 
information and statistics on Australia’s health and welfare. It is an independent statutory 
authority established in 1987, governed by a management board, and accountable to the 
Australian Parliament through the Health portfolio. 
The AIHW aims to improve the health and wellbeing of Australians through better health 
and welfare information and statistics. It collects and reports information on a wide range of 
topics and issues, ranging from health and welfare expenditure, hospitals, disease and 
injury, and mental health, to ageing, homelessness, disability and child protection. 
The AIHW also plays a role in developing and maintaining national metadata standards. 
This work contributes to improving the quality and consistency of national health and 
welfare statistics. The Institute works closely with governments and non-government 
organisations to achieve greater adherence to these standards in administrative data 
collections to promote national consistency and comparability of data and reporting. 
One of the AIHW’s main functions is to work with the states and territories to improve the 
quality of administrative data and, where possible, to compile national data sets based on 
data from each jurisdiction, analyse these data sets, and disseminate information and 
statistics. 
The Australian Institute of Health and Welfare Act 1987, in conjunction with compliance to the 
Privacy Act 1988 (Cwlth), ensures that the data collections managed by the AIHW are kept 
securely and under the strictest conditions with respect to privacy and confidentiality. 
For further information, see the AIHW website: <http://www.aihw.gov.au/>. 
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Data for the NSABDC were supplied to the AIHW by state and territory health authorities 
for the purpose of reporting against the National Healthcare Agreement (NHA) performance 
benchmark and performance indicator ‘Healthcare-associated infections’ and for reporting 
by the National Health Performance Authority (NHPA). Data were provided to AIHW by 
private hospitals for reporting by the NHPA. 
Timeliness 
The reference period for this data set is 1 July 2012 to 30 June 2013. Data are provided 
annually by state and territory health authorities. The original timetable was for states and 
territories to provide the data by 27 September 2013. States and territories provided the data 
to the AIHW in September and October 2013. The data were published in December 2013.  
Data are also provided annually by private hospitals and private hospital groups.  
Accessibility 
The AIHW publishes data from the NSABDC annually in the Australian hospital statistics: 
Staphylococcus aureus bacteraemia in Australian public hospitals series. These reports may be 
accessed on the AIHW website: <http://www.aihw.gov.au/hospitals/>.  
Interpretability 
Information on the definitions used for the NSABDC, including patient days, admitted 
patient, non-admitted patient and care type, are available on the AIHW’s online metadata 
repository (METeOR). METeOR can be accessed on the AIHW website: 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/181162>. 
The 2014 NHA performance indicator specification has been included in Appendix A of this 
report, and can be accessed on the METeOR website at: 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/517636>. 
Relevance 
Data from the NSABDC are used for the NHA performance benchmark and performance 
indicator about safety and quality in hospital and related care. 
If a case is associated with care provided in another jurisdiction, then it may be reported 
(where known) by the jurisdiction where the care associated with the SAB occurred. 
Almost all cases of SAB will be diagnosed when the patient is an admitted patient. However, 
the intention is that cases are reported whether they were determined to be associated with 
admitted patient care or non-admitted patient care in public hospitals. 
The count of patient days reflects the amount of admitted patient activity, but does not 
reflect the amount of non-admitted patient activity. The amount of hospital activity that 
patient days reflect varies among jurisdictions and over time because of variation in 
admission practices. 
Accuracy 
States and territories are primarily responsible for the quality of the data they provide. 
However, the AIHW undertakes validations on receipt of data. Data are checked for valid 
values, logical consistency and historical consistency. Potential errors are queried with 
jurisdictions, and corrections and resubmissions may be made in response to these edit 
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queries. The AIHW does not adjust data to account for possible data errors or missing or 
incorrect values, except as stated. 
The arrangements for the collection of data by hospitals and the reporting to state and 
territory health authorities may vary among the jurisdictions. Jurisdictional manuals should 
be referred to for full details of definitions used in their infection surveillance arrangements. 
For most states and territories, there is less than 100% coverage of public hospitals.  
There may be imprecise exclusion of some SAB cases due to the inherent difficulties in 
determining the origins of SAB episodes, such as those originating in non-hospital health 
care settings. However, it is likely that the number of cases incorrectly included or excluded 
would be small. 
The patient day data may be preliminary for some hospitals or jurisdictions. 
Coherence 
The NSABDC data were first reported for 2008–09 in the 2010 COAG Reform Council 
National Agreement performance information 2008–09: National Healthcare Agreement (SCRGSP 
2009). The 2008–09 data were provided by five jurisdictions only and before the development 
of an agreed national definition of a case of SAB. These data were limited to principal referral 
and large hospitals only. For these reasons, 2008–09 data are not comparable with those 
reported subsequently, with the exception of data for Tasmania.  
NSABDC data for 2009–10 were presented in the 2011 COAG Reform Council National 
Healthcare Agreement: performance report for 2009–10 (CRC 2011). New South Wales used a 
definition of SAB that differed from the national definition.  
NSABDC data for 2010–11 were presented in Australian hospital statistics 2010–11: 
Staphylococcus aureus bacteraemia in Australian public hospitals (AIHW 2011) and in the 2012 
COAG Reform Council National Healthcare Agreement: performance report for 2010–11 (CRC 
2012). 
NSABDC data for 2011–12 were presented in Australian hospital statistics 2011–12: 
Staphylococcus aureus bacteraemia in Australian public hospitals (AIHW 2013c) and in the 2013 
COAG Reform Council National Healthcare Agreement: performance report for 2011–12 (CRC 
2013). 
Due to the changes in the performance indicator specification, the data originally published 
for 2010–11 (in Australian hospital statistics 2010–11: Staphylococcus aureus bacteraemia in 
Australian public hospitals (AIHW 2011)) are not comparable with the data published in later 
reports. In 2012, the scope of the indicator was revised to include unqualified newborns. 
Data reported for 2010–11 and subsequent years include unqualified newborns, except for 
Western Australia where unqualified days for newborns were not included in 2010–11 and 
2011–12 data.  In addition, hospital boarders and posthumous organ procurement episodes 
were explicitly excluded from the data from 2011–12.  
Data for 2011–12 have been updated for Victoria, Western Australia, South Australia, 
Tasmania and the Australian Capital Territory since previously published. 
Data for 2010–11, 2011–12 and 2012–13 published in Australian hospital statistics 2012–13: 
Staphylococcus aureus bacteraemia in Australian public hospitals are comparable for most states 
and territories, and are considered comparable at the national level. However, the data 
should be interpreted with caution due to the following issues: 
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• Data for Queensland for 2010–11 include only patients aged 14 and over, while from 
2011–12 onwards, all age groups are included. 
• For 2010–11 and 2011–12, the Western Australian data exclude unqualified days for 
newborns, specialised psychiatric care units and psychiatric hospitals. Therefore, the 
2010–11 and 2011–12 SAB data for Western Australia are not comparable with data from 
other jurisdictions for those two years. For 2012–13, Western Australia was able to 
provide the data as specified. 
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Glossary 
admitted patient: A patient who undergoes a hospital’s admission process to receive 
treatment and/or care. This treatment and/or care is provided over a period of time and can 
occur in hospital and/or in the person’s home (for hospital-in-the-home patients).  
METeOR id: 268957. 
antimicrobial resistance: Occurs where a microorganism develops ways to survive exposure 
to an antimicrobial medicine that could previously kill or weaken it. 
bacteraemia: A bacterial infection of the blood or the lymph system.  
bloodstream infection: The presence of live microorganisms in the blood.  
casemix: The range and types of patients (the mix of cases) treated by a hospital or other 
health service. Casemix classifications (such as Australian Refined - Diagnosis Related 
Groups) provide a way of describing and comparing hospitals and other services for 
management purposes. 
healthcare-associated infection: An infection acquired as a direct or indirect result of health 
care.  
infection: The invasion and reproduction of microorganisms inside the body. This can cause 
tissue injury and disease.  
methicillin-resistant Staphylococcus aureus (MRSA): A strain of Staphylococcus aureus that 
can survive treatment with the antibiotics normally used to treat Staphylococcus aureus 
infections. METeOR id: 391098.  
methicillin-sensitive Staphylococcus aureus (MSSA): Strains of Staphylococcus aureus that 
are sensitive to treatment with the antibiotics commonly used to treat infections.  
METeOR id: 458522. 
non-admitted patient: A patient who receives care from a recognised non-admitted patient 
service or clinic of a hospital. METeOR id: 268973. 
patient days: The total number of days for patients who were admitted for an episode of care 
and who separated during a specified reference period. A patient who is admitted and 
separated on the same day is allocated one patient day. METeOR id: 270045. 
private hospital: A privately owned and operated institution, catering for patients who are 
treated by a doctor of their own choice. Patients are charged fees for accommodation and 
other services provided by the hospital and relevant medical and paramedical practitioners. 
Acute care and psychiatric hospitals are included, as are private free-standing day hospital 
facilities.  
public hospital: A hospital controlled by a state or territory health authority. Public 
hospitals offer free diagnostic services, treatment, care and accommodation to all eligible 
patients.  
qualified days: The number of qualified days within newborn episodes of care for babies 
aged 9 days old or less admitted to hospital. Days within newborn episodes of care are either 
qualified or unqualified. A newborn day is acute (qualified) when a newborn meets at least 
one of the following criteria:  
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• is the second or subsequent live born infant of a multiple birth, whose mother is 
currently an admitted patient  
• is admitted to an intensive-care facility in a hospital, being a facility approved by the 
Australian Government Health Minister for the purpose of the provision of special care  
• remains in hospital without its mother  
• is admitted to the hospital without its mother. See METeOR id: 268957.  
Unqualified newborn days are those days that do not meet these criteria. 
separation: An episode of care for an admitted patient, which can be a total hospital stay 
(from admission to discharge, transfer or death) or a portion of a hospital stay beginning or 
ending in a change of type of care (for example, from acute to rehabilitation).  
Separation also means the process by which an admitted patient completes an episode of 
care—by being discharged, dying, transferring to another hospital or changing type of care. 
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In 2012–13, all states and territories had rates of 
hospital-associated Staphylococcus aureus bacteraemia 
(SAB) below the national benchmark, with rates ranging 
from 0.7 to 1.3 cases per 10,000 patient days.
There were 1,724 cases of hospital-associated SAB  
reported for Australia, which occurred during 
approximately 18.8 million days of patient care. 2012–13
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